- 科普:西安进口MCE品牌清关代理 MedChemExp产品,有优惠活动吗?
- 生物物理学_生物科学类图书【推荐正版价格】_图书当当网
- Brefeldin A,简称BFA,是一种常用的蛋白转运抑制剂。请问一下它的...
- SigmaAldrich 品牌介绍及代理商/经销商名单品牌 ...
- MedChemExpress(MCE) 品牌介绍及代理商/经销商名单品牌专区...
- Doxycyclinehydrochloride _ MMP 抑制剂 MedChemExpress_图文...
- Brefeldin A,简称BFA,是一种常用的蛋白转运抑制剂。请问一下它的...
- 空运代理服装/货代海运代理瑞典哈尔姆斯塔德「货运站」
- 独立法人
- ID8 | DYRK 抑制剂| MCE
- MCE
- GSK2837808A前沿研究进展评论列表_新药快讯_新药汇
| Description | VerteporfinisabenzoporphyrinderivativemonoacidringA,andcaninhibittheactivityofYAP. |
|---|---|
| InVitro | VerteporfinisspecificallyselectedbyPDX-cellscreening.Theconcentrationstocause50%growthinhibition(GI50)forPhLO,PhLH,andPhLKare228nM,395nM,and538nM,respectively,whereasGI50forALL-1,TCC-Y/sr,andNPhA1are3.93µM,2.11µM,and5.61µM,respectively.GSHsignificantlyreducesthesensitivityof2outof3PDXcellstoverteporfin.VerteporfinreducesthemitochondrialmembranepotentialinPDXcells[1].VerteporfinreducesthePTX-resistanceonHCT-8/TcellsbyinhibitingYAPexpressionandcombinationtherapywithverteporfinandpaclitaxel(PTX)showssynergismoninhibitionofYAPandcytotoxicitytoHCT-8/T[2]. |
| InVivo | Verteporfin(10mg/kg,c.s.c.)anddasatinibsignificantlyreducestheleukemiacellratio,andcombinedtherapyfurtherreducedthenumberofleukemiacellsinthespleen[1]. |
| ClinicalTrial | ViewMoreCollapse |
| References |
|
| PreparingStockSolutions |
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent. | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellAssay [1] | VerteporfinisdissolvedinDMSO. PDXcellsco-culturedwithS17cellsaretreatedwith16combinationsofverteporfin(60nM,120nM,180nM,and240nM)anddasatinib(12nM,24nM,36nM,and48nM).TheviABIlitiesofcellstreatedwitheachcombinationaremeasuredafter48husingFACSAriaflowcytometer.Inordertoestimatedruginteractionbetweenverteporfinanddasatinib,anormalizedisobologramandfractionaffectedcombinationindex(CI)plotaremadeusingCompuSynsoftware.CIvaluesgreaterthan1.0indicatedantagoNISTiceffects,equalto1.0additiveeffects,andbelow1.0synergisticeffects.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. | ||||||||||||||||||||||||||
| AnimalAdministration [1] | PhLOcells(1.0×107/mouse)areinjectedintravenouslyinto6-week-oldmaleNOGmice,whicharethentreatedwithvehicle,verteporfin(140mg/kg/day),dasatinib(20mg/kg/day),andacombinationofthesedrugsfromdays22to28.Verteporfinisadministeredbycontinuoussubcutaneousinfusion(c.s.c.)usingAlzetosmoticpumps.Anintraperitonealinjection(i.p.)isperformedfordasatinib.Allmicearesacrificedonday28andthechimerismofleukemiacellsisinvestigatedbyflowcytometerusingananti-humanCD19antibodyandantimouseCD45antibody.BloodconcentrationsofverteporfinarecalculatedbyLCMS-2020.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly. References |
|


